Stars in the Night Sky: iPSC-Cardiomyocytes Return the Patient Context to Drug Screening.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 30951657.
- Also identified by DOI 10.1016/j.stem.2019.03.013.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
iPSC-derived cardiomyocytes have the potential to revolutionize the discovery of new medicines for serious heart conditions; however, heart failure remains a major cause of mortality worldwide. In this issue of Cell Stem Cell, Fiedler et al. (2019) describe using iPSC-derived cardiomyocytes to screen new chemical entities, discovering a small molecule for ischemic injury.
Medical subject headings
- Induced Pluripotent Stem Cells
- Myocytes, Cardiac